Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-024188
Filing Date
2025-09-10
Accepted
2025-09-10 19:32:41
Documents
2
Period of Report
2025-09-10

Document Format Files

Seq Description Document Type Size
1 form3-09102025_110937.html 3  
1 form3-09102025_110937.xml 3 1671
2 ex24-09102025_110937.htm EX-24 5137
  Complete submission text file 0001415889-25-024188.txt   8303
Mailing Address 575 MADISON AVENUE NEW YORK NY 10022
Business Address 575 MADISON AVENUE NEW YORK NY 10022 917-450-6581
LB PHARMACEUTICALS INC (Issuer) CIK: 0001691082 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LB PHARMACEUTICALS INC 575 MADISON AVENUE NEW YORK NY 10022
Business Address
Luse Rebecca (Reporting) CIK: 0002031342 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42831 | Film No.: 251306925